Reader’s Digest, September 2010. In 2009, a study by Congress’s Government Accountability Office found that the safety and efficacy of many of the riskiest devices on the market have never been proved. The FDA’s oversight of medical products is broken.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
The Effects of a Controversial Cancer Drug
Washington Post, Letters to the Editor, August 22, 2010. Research shows that breast cancer patients taking Avastin don’t live as long and they have more serious side effects than patients taking placebo. That is why Avastin should not be used for breast cancer, even if it were free.
Read More »F.D.A. Approves 5-Day Emergency Contraceptive
The New York Times, August 14, 2010. It’s important the F.D.A. made a decision that’s based on the scientific evidence and not on the political controversy.
Read More »Cancer Drug Avastin no Longer Recommended for Women with Advanced Breast Cancer
KTNV, Jul 21, 2010. “It is not saving lives and in fact women taking this drug seem to die a little sooner than women taking other drugs,” said Diana Zuckerman.
Read More »Cancer Drug Avastin Has Major Setback
Kezi, July 21, 2010. “It is not saving lives, and in fact women taking this drug seem to die a little sooner than women taking other drugs.”
Read More »